Pulmonary and psoas muscle nocardiosis in a patient with lupus nephritis: a case report and review of the literature.
The incidence of nocardiosis is increasing with the expansion of immunosuppressive therapy and improvement of laboratory diagnostic methods. Nocardiosis could be fatal in the compromised host. Some Nocardia species are known to be multi-drug resistant. Thus, early recognition and identification of Nocardia species are important for patient treatment and outcome. Recently, we treated a patient with pulmonary and psoas muscle nocardiosis in a woman taking prednisolone for lupus nephritis; the isolated organism was Nocardia farcinica identified by polymerase chain reaction-restriction fragment length polymorphism testing.
Noh
Ji Yun
JY
Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Korea University Guro Hospital, 97 Gurodong-Gil, Guro-Gu, Seoul, 152-703, Republic of Korea.
Cheong
Hee Jin
HJ
Heo
Jung Yeon
JY
Choi
Won Suk
WS
Jo
Yu Mi
YM
Song
Joon Young
JY
Lee
Chang Kyu
CK
Kim
Sung Il
SI
Kim
Woo Joo
WJ
D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects; D006801:Humans; D008181:Lupus Nephritis / Q000150:complications* / Q000188:drug therapy; D008875:Middle Aged; D009220:Myositis / Q000382:microbiology*; D009617:Nocardia Infections / Q000150:complications* / Q000473:pathology; D011239:Prednisolone / Q000009:adverse effects; D016658:Psoas Muscles / Q000382:microbiology*
D005938:Glucocorticoids; D011239:Prednisolone